道彤投资

道彤投资

@daltonventure

以生命科学为根,向硬科技生长

111 articles

Articles

China's first domestically made phaco-vitrectomy machine wins investor recognition as Rhino Health closes new funding round | Dalton Venture Family

China's first domestically made phaco-vitrectomy machine wins investor recognition as Rhino Health closes new funding round | Dalton Venture Family

Recently, **Dalton Venture portfolio company Rhino Health, a developer of high-end ophthalmic surgical equipment, has completed a nearly RMB 100 million Series B+ funding round**. The round was led by IN Capital, with Zhuhai Technology Industry Group participating. The proceeds will be used primarily for regulatory registration of Rhino Health's innovative ophthalmic products, overseas expansion of existing products, and domestic commercialization efforts.

Brain-Computer Interface, Beyond Imagination | Dalton Venture × HuaBrain Safety: Before Risk Strikes, the Brain Knows First

Brain-Computer Interface, Beyond Imagination | Dalton Venture × HuaBrain Safety: Before Risk Strikes, the Brain Knows First

From science fiction to reality, brain-computer interfaces are drawing closer. As humans gain the ability to read, understand, and even intervene in the brain, a new question emerges: where, exactly, will brain-computer interfaces take us?

CCTV's Top Ten AI Startups: The Only AI Drug Company Is Tsinghua-Affiliated | Dalton Venture Family

CCTV's Top Ten AI Startups: The Only AI Drug Company Is Tsinghua-Affiliated | Dalton Venture Family

Recently, **Dalton Venture portfolio company Shuimu Molecule Biotechnology Co., Ltd. (hereinafter referred to as "Shuimu Molecule")** emerged from 1,200 applicants worldwide in the "**2026 Win in AI+**" entrepreneurship gala, co-hosted by China Media Group and the Hangzhou Municipal Government. After multiple rounds of competition, it **was named one of the "Top Ten AI Visionaries" — the only AI drug discovery company on the list**.

After Brain-Computer Interfaces, Before the Future | SEF EVENTS × Dalton Venture Tong Academy Event Recap

After Brain-Computer Interfaces, Before the Future | SEF EVENTS × Dalton Venture Tong Academy Event Recap

Building a company all the way to an IPO is a long and arduous journey. While startups relentlessly pursue breakthroughs in technology and innovation, they must also navigate challenges across corporate strategy, business models, capital operations, and day-to-day management.

Yuanshi Tech Closes Two Consecutive Rounds Near 100 Million Yuan, Dalton Venture Bets on AI General Cell Model to Accelerate Virtual Cell Technology

Yuanshi Tech Closes Two Consecutive Rounds Near 100 Million Yuan, Dalton Venture Bets on AI General Cell Model to Accelerate Virtual Cell Technology

Recently, **YuanShi Technology announced that it has completed consecutive angel and angel+ funding rounds totaling nearly RMB 100 million. The angel round was co-led by Sinovation Ventures, Shanghai Future Industry Fund, and YanYuan Venture Capital; the angel+ round was invested by Monolith and Aochuang Pioneer Fund**, with the latter being co-established by Dalton Venture and listed industry player OPM Biosciences — the first bio-manufacturing industry CVC fund in the Yangtze River Delta region. **The proceeds from this round will mainly be**

Brain-Computer Interfaces, Beyond Imagination | Dalton Venture × Gestalt Technology: When Brain-Computer Interfaces Begin to See the Whole Brain

Brain-Computer Interfaces, Beyond Imagination | Dalton Venture × Gestalt Technology: When Brain-Computer Interfaces Begin to See the Whole Brain

From science fiction to reality, brain-computer interfaces are drawing closer. As humans gain the ability to read, understand, and even intervene in the brain, a new question emerges: where exactly will brain-computer technology take us?

Astribot raises another 1 billion yuan in fourth funding round within six months, accelerating mass production of cable-driven AI robots | Dalton Venture

Astribot raises another 1 billion yuan in fourth funding round within six months, accelerating mass production of cable-driven AI robots | Dalton Venture

Recently, **Astribot — a Dalton Venture portfolio company and the world's first company to mass-produce cable-driven AI robots — has completed a new funding round of approximately one billion yuan. The company is now valued at 15 billion yuan, firmly securing its place in the top tier of China's Embodied Artificial Intelligence companies.** This round was led by Shenzhen Investment Holdings Donghai (a subsidiary of Shenzhen Investment Holdings), with participation from Hongtai APlus, Ninghai Xingtaihe Fund managed by Guanghua Yangguang, Shanheng Capital, and other key state-owned and financial investors, as well as existing shareholder Xianmu...

Xizi Shenge Secures New Funding Round, Launches Scaled Construction of Synthetic Biology Production Base | Dalton Venture Family

Xizi Shenge Secures New Funding Round, Launches Scaled Construction of Synthetic Biology Production Base | Dalton Venture Family

Recently, a Dalton Venture portfolio company — **Hangzhou Xizi Shenghe Technology Co., Ltd.** — received exclusive strategic investment from Henan HuiRong Fund and established a strategic partnership with the biomanufacturing pilot base under Henan Investment Group.